HIM
CPHR

Hillsdale Investment Management’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Hillsdale Investment Management’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-79,440
Closed -$1.15M – 602
2014
Q4 		$1.15M Buy
+79,440
New +$1.15M 0.3% 59

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Hillsdale Investment Management's CPHR Position: Q1 2015 in Review

Hillsdale Investment Management sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q1 2015, closing a stake of 79,440 shares — an estimated $1.15M sold.

Hillsdale Investment Management first reported a position in CPHR in Q4 2014 and held it in 1 quarter. The position peaked at $1.15M in Q4 2014. 31 funds tracked by Wall St. Rank hold CPHR as of Q1 2015.

  • Hillsdale Investment Management reported no remaining Cipher Pharmaceuticals Inc. position as of Q1 2015 after selling out during the quarter.
  • Hillsdale Investment Management sold 79,440 Cipher Pharmaceuticals Inc. shares in Q1 2015, an estimated $1.15M.
  • Hillsdale Investment Management first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 1 quarter.
  • Hillsdale Investment Management's Cipher Pharmaceuticals Inc. position peaked at $1.15M in Q4 2014.
  • 31 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q1 2015.

Based on Hillsdale Investment Management's 13F filing for Q1 2015, filed 12 May 2015.